Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mitoxantrone, Cytarabine, Cyclophosphamide, Etoposide, and Interferon Alfa in CML Blast Crisis
NCT00002598Phase 2Completed
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Start
- Jun 1994
- Primary completion
- Jun 2004
- Modality
- DNA Intercalators/Alkylators, Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 2 trial of mitoxantrone, cytarabine, cyclophosphamide, etoposide, interferon alfa in chronic myelogenous leukemia (CML), sponsored by Memorial Sloan Kettering Cancer Center. Started Jun 1994; status: completed.
02
Drugs
mitoxantronecytarabinecyclophosphamideetoposideinterferon alfa
03
Conditions
chronic myelogenous leukemia (CML)
Beyond the preview
Go deeper on NCT00002598.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00002598.